BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32889350)

  • 1. An LC-MS/MS analytical method for the determination of uremic toxins in patients with end-stage renal disease.
    Ma YR; Xin MY; Li K; Wang H; Rao Z; Liu TX; Wu XA
    J Pharm Biomed Anal; 2020 Nov; 191():113551. PubMed ID: 32889350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of uremic toxins in advanced chronic kidney disease patients on maintenance hemodialysis by LC-ESI-MS/MS.
    Ragi N; Pallerla P; Babi Reddy Gari AR; Lingampelly SS; Ketavarapu V; Addipilli R; Chirra N; Kantevari S; Yadla M; Sripadi P
    Metabolomics; 2023 Feb; 19(3):14. PubMed ID: 36826619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury.
    André C; Bennis Y; Titeca-Beauport D; Caillard P; Cluet Y; Kamel S; Choukroun G; Maizel J; Liabeuf S; Bodeau S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122234. PubMed ID: 32615535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation, clearance, toxicity, and monitoring possibilities of unaccounted uremic toxins for improved dialysis prescriptions.
    Atherton JG; Hains DS; Bissler J; Pendley BD; Lindner E
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F890-F902. PubMed ID: 29537310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Uremic Score Reflecting Accumulation of Specific Uremic Toxins More Precisely Predicts One-Year Mortality after Hemodialysis Commencement: A Retrospective Cohort Study.
    Arai Y; Shioji S; Tanaka H; Katagiri D; Hinoshita F
    Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers.
    Fabresse N; Larabi IA; Abe E; Lamy E; Rigothier C; Massy ZA; Alvarez JC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Serum Levels of Protein-Bound Uremic Toxins in Hemodialysis Patients Measured by LC/MS/MS.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Mass Spectrom (Tokyo); 2013; 2(Spec Iss):S0017. PubMed ID: 24349936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and sensitive method for simultaneous determination of eight protein-bound uremic toxins in human serum by UHPLC-MS/MS: application in assessing peritoneal dialysis.
    Wang Z; Jiang H; Chen X; Song X; Xu F; Chen F; Mao Z; Gao S; Chen W
    J Pharm Biomed Anal; 2020 Jul; 186():113312. PubMed ID: 32361090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adsorption- and Displacement-Based Approaches for the Removal of Protein-Bound Uremic Toxins.
    Rodrigues FSC; Faria M
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
    van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38.
    Katsube Y; Tsujimoto M; Koide H; Ochiai M; Hojyo A; Ogawa K; Kambara K; Torii N; Shima D; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):783-789. PubMed ID: 28314987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of free and protein bound uremic toxins in human serum by LC-MS/MS: Comparison of rapid equilibrium dialysis and ultrafiltration.
    Fabresse N; Uteem I; Lamy E; Massy Z; Larabi IA; Alvarez JC
    Clin Chim Acta; 2020 Aug; 507():228-235. PubMed ID: 32371217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantitative analysis of uremic toxins by LC-MS/MS with a reversed-phase/cation-exchange/anion-exchange tri-modal mixed-mode column.
    Kanemitsu Y; Asaji K; Matsumoto Y; Tsukamoto H; Saigusa D; Mukawa C; Tachikawa T; Abe T; Tomioka Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():1-8. PubMed ID: 29024911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients.
    Cupisti A; Bolasco P; D'Alessandro C; Giannese D; Sabatino A; Fiaccadori E
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33921862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney disease.
    Prokopienko AJ; West RE; Stubbs JR; Nolin TD
    J Pharm Biomed Anal; 2019 Sep; 174():618-624. PubMed ID: 31276982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-Arrhythmic Potential of Accumulated Uremic Toxins Is Mediated via Vulnerability of Action Potential Repolarization.
    van Ham WB; Cornelissen CM; Polyakova E; van der Voorn SM; Ligtermoet ML; Monshouwer-Kloots J; Vos MA; Bossu A; van Rooij E; van der Heyden MAG; van Veen TAB
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.